Likelihood Of Placental-Site Trophoblastic Tumors Linked To The Amount Of Time Since Related Pregnancy

An article published Online First and in a future edition of The Lancet discusses the management of a rare condition called placental-site trophoblastic tumors (PSTTs). They are malignant tumors usually presenting months to years after pregnancy. The chances of surviving those tumors are linked to how much time elapsed since the related pregnancy took place.

Free Mammograms Available Through Minnesota Department Of Health - Newly Enrolled Women Will Also Receive A $20 Bonus

The Minnesota Department of Health (MDH) will offer free mammograms through a televised phone bank on FOX 9 KMSP-TV in Minneapolis on Thursday, June 25, 2009. The phone bank will air during the 5 p.m., 5:30 p.m., 9 p.m. and 10 p.m. newscasts. The mammograms are offered through the Sage Screening Program, a state and [...]

Midlife Migraine With Aura Linked To Brain Lesions In Later Life

An international team of researchers found that middle-aged women who had migraines with aura (perceptual disturbance that may precede or accompany the migraine such as a strange light or smell, or disturbed balance or speech) were more likely to develop brain lesions when they were older compared [...]

Adults with Asthma Under-Vaccinated Against Flu (CME/CE)

LITTLE FALLS, N.J. (MedPage Today) — Most adult asthmatics are not getting recommended flu shots, researchers found.

Driving Restrictions for ICD Patients Shortened (CME/CE, with audio)

SAN FRANCISCO (MedPage Today) — Patients don’t need to wait as long to get back on the road after receiving an implantable cardioverter defibrillator (ICD) under updated European guidelines.

Six Patient Behaviors That Drive Doctors Nuts

WHEELING, W.Va. (MedPage Today) — Here’s how people can earn a notation of “difficult patient” on their charts.

Clinical trial raises hope for Australian diabetics to be insulin free

A clinical trial for a new treatment for type 1 diabetes which potentially eliminates the need for daily insulin injections will commence in New Zealand by Australian company Living Cell Technologies (LCT).

Also In Global Health News: Venezuela Voids Pharma Patents; Namibia Sanitation; Mapping Disease With Satellites; Zimbabwe Health Funding

Venezuela To Void Some Pharmaceutical Patents Commerce Minister Eduardo Saman on Saturday said Venezuela plans to void some pharmaceutical patents and allow domestic manufacturers to produce licensed medicines, the AP/Buffalo News reports.

WorldCare Clinical Implements MCC’s Imaging Performance Metrics In Support Of Standardized Peformance For Imaging Trials

45th DIA Annual Meeting — Booth # 1501 — WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology and medical device industries, announced that it is offering version 1.0 of the Metrics Champion Consortium (MCC) Imaging Performance Metrics to all sponsors’ imaging trials beginning July 1, 2009, through its [...]

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) For The Treatment Of Fabry Disease

Amicus Therapeutics (Nasdaq: FOLD) announced it has commenced the U.S. registration Phase 3 trial with its investigational drug, Amigal(TM) (migalastat hydrochloride) for the treatment of Fabry disease. The Company has reached agreement with the U.S.